Best Practices in Meningococcal B Disease Prevention
PROGRAM DESCRIPTION Meningococcal disease, specifically serotype B (MenB), is an ongoing problem in this country, particularly in light of recent university outbreaks. The disease can develop from initial symptoms to ...
Meningococcal disease, specifically serotype B (MenB), is an ongoing problem in this country, particularly in light of recent university outbreaks. The disease can develop from initial symptoms to death within 24 hours, and as many as 20% of survivors have permanent sequelae. Notably, incidence rates are often a misconception due to underdetection and under-reporting. Given how disabling diseases can be that could have been prevented with vaccination, it is essential that healthcare workers delivering vaccinations enhance their standards of care in practice in order to deliver the highest rates of preventative care. The goal of the activity is to improve comprehension and initiate practice changes so as to improve immunization rates for all patients who are currently scheduled for the MenB vaccination.
Upon completion of these activities, participants should be better able to:Discuss the current epidemiology of MenB in the United States and the profiles of patients at greatest risk for this vaccine-preventable diseaseDescribe recent MenB immunization recommendations made by the Advisory Committee on Immunization Practices (ACIP) and the rationale behind a category B classificationExamine the mechanism of action, contraindications, and adverse effect profiles of current MenB vaccinesGiven a patient case, recognize best practices in counseling patients and their parents/caregivers on the importance of administering the MenB vaccineDiscuss practice considerations for administering the MenB vaccine such as documentation, billing, and screening for additional immunizations
I'm interested in this
Share with others
Write the first review
Share with others